Allogene Therapeutics

0 followers


Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

David Chang
President, CEO & Co-Founder

David Chang

Collapse
Barbra Sasu
Chief Scientific Officer
Christine Cassiano
Chief Communications Officer
Susan Lundeen
Chief People Officer
Tim Moore
EVP & CTO
Zachary J. Roberts
EVP, Research & Development & CMO
Earl Douglas
General Counsel
Diane Hagerty
SVP of Quality
Stephen Hardt
SVP of Supply Chain & External Manufacturing
Jack Chen
Svp, Finance
Monique D.
Executive Asst To CMO CSO VP Biometrics VP Clinical Operations VP Global Regulatory Affairs
Shalini Gidwani
Senior Vice President, Global Regulatory Affairs
Marjan Shamsaei Pharm.d.
Vp, Head Of Commercial
Eike Zimmermann
Senior Director Product Quality Lead
Wei-Meng Zhao
Senior Director, Product Quality Leader